LCN2 and Parkinson disease: The mRNA and protein expression levels of LCN2 increased in the substantia nigra and striatum in two neurotoxin mouse PD models (MPTP and 6-OHDA), and LCN2 promoted neuro-inflammation and neuronal death, leading to the disruption of the dopamine pathway in the SN which caused motor behavior disorder (51).